275 related articles for article (PubMed ID: 27231577)
1. Motor fluctuations due to interaction between dietary protein and levodopa in Parkinson's disease.
Virmani T; Tazan S; Mazzoni P; Ford B; Greene PE
J Clin Mov Disord; 2016; 3():8. PubMed ID: 27231577
[TBL] [Abstract][Full Text] [Related]
2. Protein-Restricted Diets for Ameliorating Motor Fluctuations in Parkinson's Disease.
Wang L; Xiong N; Huang J; Guo S; Liu L; Han C; Zhang G; Jiang H; Ma K; Xia Y; Xu X; Li J; Liu JY; Wang T
Front Aging Neurosci; 2017; 9():206. PubMed ID: 28701947
[TBL] [Abstract][Full Text] [Related]
3. Levodopa Effect and Motor Function in Late Stage Parkinson's Disease.
Rosqvist K; Horne M; Hagell P; Iwarsson S; Nilsson MH; Odin P
J Parkinsons Dis; 2018; 8(1):59-70. PubMed ID: 29480220
[TBL] [Abstract][Full Text] [Related]
4. Various aspects of motor fluctuations and their management in Parkinson's disease.
Mizuno Y; Kondo T; Mori H
Neurology; 1994 Jul; 44(7 Suppl 6):S29-34. PubMed ID: 8047258
[TBL] [Abstract][Full Text] [Related]
5. Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model.
de la Fuente-Fernández R; Schulzer M; Mak E; Calne DB; Stoessl AJ
Brain; 2004 Apr; 127(Pt 4):888-99. PubMed ID: 14960500
[TBL] [Abstract][Full Text] [Related]
6. [Direct switch from conventional levodopa to stalevo (levodopa/carbidopa/entacapone) improves quality of life in Parkinson's disease: results of an open-label clinical study].
Litvinenko IV; Odinak MM; Mogil'naia VI; Sologub OS; Sakharovskaia AA
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(1):51-4. PubMed ID: 19156087
[TBL] [Abstract][Full Text] [Related]
7. Risk and course of motor complications in a population-based incident Parkinson's disease cohort.
Bjornestad A; Forsaa EB; Pedersen KF; Tysnes OB; Larsen JP; Alves G
Parkinsonism Relat Disord; 2016 Jan; 22():48-53. PubMed ID: 26585090
[TBL] [Abstract][Full Text] [Related]
8. Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study.
Schrag A; Quinn N
Brain; 2000 Nov; 123 ( Pt 11)():2297-305. PubMed ID: 11050029
[TBL] [Abstract][Full Text] [Related]
9. Medical management of levodopa-associated motor complications in patients with Parkinson's disease.
Jankovic J; Stacy M
CNS Drugs; 2007; 21(8):677-92. PubMed ID: 17630819
[TBL] [Abstract][Full Text] [Related]
10. The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study.
Bracco F; Battaglia A; Chouza C; Dupont E; Gershanik O; Marti Masso JF; Montastruc JL;
CNS Drugs; 2004; 18(11):733-46. PubMed ID: 15330687
[TBL] [Abstract][Full Text] [Related]
11. Bromocriptine versus levodopa in early Parkinson's disease.
Ramaker C; van Hilten JJ
Cochrane Database Syst Rev; 2000; (3):CD002258. PubMed ID: 10908538
[TBL] [Abstract][Full Text] [Related]
12. [Motor fluctuations and dyskinesias in Parkinson's disease: variables that discriminate both complications in a sample of 285 patients].
Gómez JC; Rouco I; Velasco F; Tijero B; Garamendi I; Lezcano E; Zarranz JJ
Neurologia; 2008 Oct; 23(8):494-8. PubMed ID: 18770057
[TBL] [Abstract][Full Text] [Related]
13. Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial.
Hauser RA; Olanow CW; Kieburtz KD; Pourcher E; Docu-Axelerad A; Lew M; Kozyolkin O; Neale A; Resburg C; Meya U; Kenney C; Bandak S
Lancet Neurol; 2014 Aug; 13(8):767-76. PubMed ID: 25008546
[TBL] [Abstract][Full Text] [Related]
14. Entacapone: a catechol-O-methyltransferase inhibitor for the adjunctive treatment of Parkinson's disease.
Najib J
Clin Ther; 2001 Jun; 23(6):802-32; discussion 771. PubMed ID: 11440283
[TBL] [Abstract][Full Text] [Related]
15. Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodopa-responsive patients with Parkinson's disease with severe motor fluctuations: a 2-year follow-up review.
Ghika J; Villemure JG; Fankhauser H; Favre J; Assal G; Ghika-Schmid F
J Neurosurg; 1998 Nov; 89(5):713-8. PubMed ID: 9817406
[TBL] [Abstract][Full Text] [Related]
16. Rapid treatment of "wearing off" in Parkinson's disease.
Swope DM
Neurology; 2004 Mar; 62(6 Suppl 4):S27-31. PubMed ID: 15037669
[TBL] [Abstract][Full Text] [Related]
17. Pathogenetic studies of motor fluctuations in Parkinson's disease.
Chase TN; Mouradian MM; Fabbrini G; Juncos JL
J Neural Transm Suppl; 1988; 27():3-10. PubMed ID: 3042912
[TBL] [Abstract][Full Text] [Related]
18. Current management of motor fluctuations in patients with advanced Parkinson's disease treated chronically with levodopa.
Melamed E; Zoldan J; Galili-Mosberg R; Ziv I; Djaldetti R
J Neural Transm Suppl; 1999; 56():173-83. PubMed ID: 10370911
[TBL] [Abstract][Full Text] [Related]
19. Management of motor fluctuations in Parkinson's disease.
Koller WC
Eur Neurol; 1996; 36 Suppl 1():43-8. PubMed ID: 8791022
[TBL] [Abstract][Full Text] [Related]
20. Force overflow and levodopa-induced dyskinesias in Parkinson's disease.
Wenzelburger R; Zhang BR; Pohle S; Klebe S; Lorenz D; Herzog J; Wilms H; Deuschl G; Krack P
Brain; 2002 Apr; 125(Pt 4):871-9. PubMed ID: 11912119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
